Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$528K Hold
5,375
0.87% 43
2020
Q1
$410K Sell
5,375
-25
-0.5% -$2.13K 0.83% 45
2019
Q4
$478K Hold
5,400
0.76% 48
2019
Q3
$409K Hold
5,400
0.69% 49
2019
Q2
$393K Hold
5,400
0.64% 54
2019
Q1
$435K Sell
5,400
-25
-0.5% -$2.04K 0.74% 45
2018
Q4
$500K Buy
5,425
+425
+9% +$37.4K 1.02% 36
2018
Q3
$473K Buy
+5,000
New +$474K 0.83% 43
2016
Q1
Sell
-15
Closed -$1K 47
2015
Q4
$1K Buy
+15
New +$864 ﹤0.01% 47

Other funds holding ABBV

Nancy B. Gardiner's ABBV Position: Q2 2020 in Review

Nancy B. Gardiner held its AbbVie (ABBV) position steady in Q2 2020 at 5,375 shares worth $528K. The position accounts for 0.87% of the portfolio, ranked #43.

Nancy B. Gardiner first reported a position in ABBV in Q4 2015 and has held it in 9 quarters since. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Nancy B. Gardiner held 5,375 shares of AbbVie worth $528K as of Q2 2020.
  • Nancy B. Gardiner left its AbbVie share count unchanged in Q2 2020.
  • AbbVie made up 0.87% of Nancy B. Gardiner's portfolio in Q2 2020, its #43 holding.
  • Nancy B. Gardiner first reported a position in AbbVie in Q4 2015 and has held it in 9 quarters since.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Nancy B. Gardiner's 13F filing for Q2 2020, filed 28 Jul 2020.